Dementia Care Q&A
Dementia Care Q&A
A conversation with the Alzheimer's Association on vaccine safety, consent, and what families of people living with dementia need to know before a facility rollout.
When COVID-19 vaccines first became available, families of people living with dementia faced a wave of unfamiliar questions: Is the vaccine safe for someone with Alzheimer's? Who can legally consent if a loved one can't? What happens if a facility's staff aren't vaccinated? CarePatrol brand president Becky Bongiovanni sat down with Kinsey McManus, program director of the Alzheimer's Association Desert Southwest Chapter, to walk through exactly these concerns. Their conversation covered vaccine safety data, consent for residents who can't make their own medical decisions, how to find out a facility's rollout plan, what happens if someone declines, and how long it takes for protection to actually take hold. Below is a breakdown of what families need to know, drawn directly from that discussion.
Vaccines were tested across ages and medical conditions and are not mandatory for residents or staff. Consent comes from a power of attorney if a loved one can't decide themselves, and full protection takes time after the second dose.
When the vaccines were first authorized, the FDA required large clinical trials that tested safety across different ages, races, ethnicities, and medical conditions, according to Kinsey McManus of the Alzheimer's Association. That broad testing is part of why the Alzheimer's Association felt comfortable recommending vaccination for people living with dementia specifically.
McManus noted that some people reported more noticeable reactions to the Pfizer vaccine compared to others, but emphasized that none of the reported complications were life-threatening. Her recommendation was straightforward: anyone with safety concerns, especially around severe allergies, should talk directly with their physician or most trusted health care provider before deciding.
This is one of the most common questions families ask, and the answer is clear: if a loved one cannot give informed consent themselves, that consent must come from their power of attorney or whichever family member is legally designated to make medical decisions on their behalf.
McManus stressed that vaccination is not mandated for residents in long-term care, so families and decision-makers retain the choice either way. Regardless of that decision, facilities are still expected to maintain access to personal protective equipment, rapid testing, and other safety measures for every resident.
McManus's core recommendation for families is to connect directly with leadership at the care community, whether that's the executive director or the director of nursing, and ask what their internal rollout plan looks like. Every facility handles logistics and communication differently.
That conversation should also cover what happens if a resident does or doesn't want the vaccine, and whether family members can be present for the process. Because staff are not mandated to get vaccinated either, McManus recommended asking directly how a facility plans to handle mixed vaccination status among both residents and employees.
| Question | Who to Ask | Key Consideration |
|---|---|---|
| Is the vaccine required? | Facility director of nursing | No — voluntary for residents and staff |
| Who consents if a loved one can't? | Power of attorney or legal decision-maker | Consent must be documented before vaccination |
| What's the local rollout timeline? | State and county health department | Varies by location and priority group |
| Already had COVID — still need it? | Primary care physician | Yes, per CDC; natural immunity duration unknown |
For a resident who is able to give or withhold consent themselves, declining is meant to be simple: telling facility staff they're not interested in taking the vaccine, and asking whether any paperwork needs to be signed to document that choice.
McManus was clear that declining now doesn't close the door permanently. Residents who decline can still choose to get vaccinated later, and the same process applies for power of attorney holders making the decision on a loved one's behalf — the choice can be revisited as circumstances change.
Families frequently ask how vaccinated a facility's staff actually is. McManus recommended contacting whoever is leading the distribution plan at that specific location to ask about their protocols for employees.
She noted that facilities are likely to be required to disclose staff vaccination percentages, as some states and municipalities have stepped in to require transparency from care facilities. Because rules vary by location, McManus advised treating this as an evolving area and checking in regularly with facility leadership.
There's no single national timeline, McManus explained, because each state determines its own distribution plan while generally following CDC guidance. That means rollout speed can differ significantly from state to state, county to county, and even within a single state.
Families should look up both their state's overarching plan and their county public health department's specific plan. If a loved one isn't in a long-term care setting, they may still fall into an early priority group due to age (75 and older) or an underlying respiratory condition. McManus also strongly recommended that caregivers themselves get vaccinated as soon as they're eligible.
McManus addressed a common assumption directly: even if someone has already had COVID-19 and likely developed some antibodies, it's still unclear how long that natural protection lasts. Because of that uncertainty, the CDC recommends getting vaccinated regardless of prior infection.
Her guidance to families was not to assume past infection provides reliable protection against getting COVID-19 again. Vaccination remains the recommended path even for residents or loved ones who have already recovered from the virus.
Once a resident receives both doses, families naturally want to know if visitation restrictions will ease. McManus acknowledged how long families have been waiting and how much residents need that contact, but cautioned that it's still early to expect major changes right as facilities begin second-dose rollouts.
Immunity takes time to build even after the second shot, and McManus pointed out that the vaccines have shown roughly 95% effectiveness in trials. Because of that lag and the fact that not everyone in a facility will be vaccinated, she recommended continuing precautions even after a loved one completes their vaccine series.
The single most useful step a family can take is reaching out to the director of nursing or administrator at the facility where a loved one lives, or to their primary physician if they're still at home. That conversation should cover the facility's specific rollout timeline, its consent process, and how it plans to handle residents and staff who decline vaccination.
This matters because so much of the answer depends on local circumstances. State and county health departments set the pace of distribution, individual communities set their own internal procedures, and physicians weigh individual risk factors like severe allergy history. No single source has the full picture, which is why direct contact with the people managing the rollout is more useful than general guidance.
For families managing consent on behalf of a loved one, confirming power of attorney status ahead of time avoids delays once a vaccination appointment is offered. Facilities need that authorization documented before proceeding, and having it ready means a loved one isn't skipped in a scheduling window that may not repeat quickly.
Finally, expect a gradual return to normal rather than an immediate one. Full protection takes time to develop after the second dose, and visitation policies are likely to loosen slowly rather than all at once. Staying in regular contact with the facility keeps families informed as those changes happen.
Vaccinating a loved one with dementia comes down to three things: confirming safety with their physician, identifying who holds legal consent authority, and staying in close contact with the care facility's rollout plan. None of it is mandatory, but staying informed prevents delays.
COVID-19 vaccination decisions for someone living with dementia rarely hinge on the disease itself — the vaccines were tested across a broad range of ages and medical conditions, and dementia is not a contraindication. What complicates things is process: figuring out who can legally consent, what a specific care community's rollout plan looks like, and how quickly protections take effect after a second dose. The clearest path forward is direct, repeated contact with the facility's director of nursing or administrator, paired with a conversation with the resident's physician about individual risk factors like severe allergies. Families who stay engaged with both the facility and their state or county health department are best positioned to make timely, informed decisions and to know what to expect once vaccination happens.
Reach out to the facility's director of nursing right away if your loved one has a history of severe allergic reactions, if you're unsure who legally holds medical decision-making authority, or if a community can't clearly explain its vaccination and PPE protocols — those gaps are worth escalating before, not after, a dose is scheduled.